Skip to main content
Clinical Trials/JPRN-UMIN000009094
JPRN-UMIN000009094
Completed
未知

Pilot study of hepatic arterial infusion chemotherapy followed by sorafenib for advanced hepatocellular carcinoma - HICS 55

Department of Gastroenterology and Metabolism,Hiroshima University Hospital0 sites55 target enrollmentOctober 11, 2012

Overview

Phase
未知
Intervention
Not specified
Conditions
advanced hepatocellular carcinoma
Sponsor
Department of Gastroenterology and Metabolism,Hiroshima University Hospital
Enrollment
55
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 11, 2012
End Date
December 31, 2016
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Department of Gastroenterology and Metabolism,Hiroshima University Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) With other malignant disease. 2\) A pregnant woman, or a woman suspected of pregnancy. 3\) With severe infectious disease. 4\) With history of severe allergy. 5\) With severe renal function disease. 6\) With severe allergy for 5FU or CDDP. 7\) With severe bone marrow supression. 8\) Esophageal and/or gastric varices which has high risk of bleeding and clinically significant gastro\- intestinal bleeding. 9\) Serious hypertension 10\) Any condition that is unstable or could jeopardize the safety of the patient and its compliance in the study, in the investigator's judgment.

Outcomes

Primary Outcomes

Not specified

Similar Trials